ZNF583 work through various biochemical pathways to modulate its activity. Forskolin acts to increase intracellular cyclic AMP (cAMP) by activating adenylate cyclase. The elevated cAMP levels can promote phosphorylation events that are believed to change the conformation of ZNF583, enhancing its DNA-binding activity. Similarly, IBMX works to prevent the degradation of cAMP by inhibiting phosphodiesterases, thus sustaining the phosphorylation state that activates ZNF583. On a different pathway, PMA activates protein kinase C (PKC), which is known to phosphorylate a wide array of proteins. The action of PKC can lead to the phosphorylation of ZNF583, thereby altering its activity. Ionomycin, by increasing intracellular calcium, can activate calcium-dependent protein kinases that may also phosphorylate and therefore activate ZNF583.
ZNF583 activity are agents that modulate chromatin structure and DNA methylation. 5-Azacytidine is incorporated into DNA where it affects methylation status, which could lead to changes in chromatin structure, thereby enhancing the DNA binding activity of ZNF583. Trichostatin A and Sodium Butyrate both act as histone deacetylase inhibitors, leading to hyperacetylation of histones. This hyperacetylation can result in a more open chromatin conformation, which may facilitate ZNF583's access to DNA. TPEN functions as a zinc chelator, and its action can disrupt the zinc-dependent conformation of ZNF583, potentially enhancing its DNA-binding activity. Conversely, Zinc Sulfate provides zinc ions, which are crucial for the structural integrity of ZNF583, ensuring its proper conformation and function. Thapsigargin disrupts calcium stores by inhibiting SERCA, possibly leading to the activation of kinases that phosphorylate ZNF583. Lastly, BIX-01294 and RG108 act on the epigenetic level; BIX-01294 inhibits the G9a histone methyltransferase, and RG108 is a DNA methyltransferase inhibitor. Both of these can alter the chromatin state, which may enhance the binding efficiency of ZNF583 to DNA.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which may lead to the activation of ZNF583 by promoting phosphorylation events that could change its conformation and enhance its DNA-binding activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP levels which in turn can enhance the activation of ZNF583 through similar mechanisms as Forskolin by maintaining phosphorylation states that are conducive to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which could phosphorylate ZNF583, leading to its functional activation as PKC-mediated phosphorylation can modulate the activity of various zinc finger proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels, which can activate calcium-dependent protein kinases that may phosphorylate and activate ZNF583 by altering its functional state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Incorporates into DNA and affects its methylation status, which could alter the chromatin structure and enhance the DNA binding activity of ZNF583, leading to its activation in regulating gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylases, causing hyperacetylation of histones which can result in a more open chromatin structure, potentially enhancing the DNA binding and activation of ZNF583 as part of gene regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor that leads to hyperacetylation of histones and could favor the activation of ZNF583 by promoting a chromatin environment that facilitates its DNA binding activity. | ||||||
TPEN | 16858-02-9 | sc-200131 | 100 mg | $127.00 | 10 | |
A zinc chelator that can disrupt intracellular zinc homeostasis, potentially altering the conformation of ZNF583 to enhance its DNA-binding and activation potential as zinc finger proteins require zinc for their structural integrity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Provides zinc ions which are essential for the structural stability of ZNF583, ensuring its proper conformation for DNA binding and activation within its role as a transcription factor. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which could lead to the activation of calcium-dependent kinases that phosphorylate and activate ZNF583. | ||||||